Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospitalArtículo Original Published on 2023-03-282024-09-05 Journal: Revista peruana de medicina experimental y salud pública [Category] update2024, [키워드] Azithromycin Azitromicina COVID-19 Farmacovigilancia Hidroxicloroquina Hydroxychloroquine Ivermectin Ivermectina pharmacovigilance Tocilizumab [DOI] 10.17843/rpmesp.2023.401.11563 PMC 바로가기 [Article Type] Artículo Original